Literature DB >> 15512960

Effect of acyclovir on thermal stress-induced herpesvirus reactivation.

Bryan M Gebhardt1, Herbert E Kaufman, James M Hill.   

Abstract

PURPOSE: Acyclovir has been shown to be effective in preventing recurrent herpes simplex virus lesions of the genitalia and oral labia. The purpose of the current study was to determine the effect of acyclovir on the appearance of infectious virus in the peripheral nervous system and in an end organ, the eye.
MATERIALS AND METHODS: Mice latent for the McKrae strain of herpes simplex virus type 1 were given 3.5 mg/ml acyclovir in their drinking water. Control animals received water without drug. Acyclovir treatment was continued for 4 successive days. On the third day, the mice were subjected to a brief period of hyperthermic stress to induce viral reactivation. Twenty-four hours after stress induction, swabs of the ocular surface and homogenates of the cornea and trigeminal ganglia were analyzed for the presence of infectious herpes simplex virus type 1 and viral DNA.
RESULTS: Acyclovir treatment significantly decreased the frequency of infectious virus in the ocular tear film and the cornea but not in the trigeminal ganglion. The corneal homogenates of acyclovir-treated animals contained smaller amounts of viral DNA compared with untreated controls, whereas the amounts of viral DNA in the trigeminal ganglia of acyclovir-treated and untreated animals were similar.
CONCLUSIONS: These results suggest that oral administration of acyclovir, at least at the dose used in this study, is effective in modestly reducing viral replication in peripheral tissues such as the eye but is not effective in inhibiting viral reactivation and viral DNA synthesis in the peripheral nervous system in mice subjected to induction of reactivation by hyperthermic stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15512960     DOI: 10.1080/02713680490504560

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  6 in total

Review 1.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

2.  Upregulation of mouse genes in HSV-1 latent TG after butyrate treatment implicates the multiple roles of the LAT-ICP0 locus.

Authors:  Christian Clement; Partha S Bhattacharjee; Manish Kumar; Timothy P Foster; Hilary W Thompson; James M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-28       Impact factor: 4.799

3.  Herpetic Keratitis Recurred after the Use of a Thermal Medical Device: A Case Report.

Authors:  Min Seung Kang; Sang Min Lee; Ji Eun Lee; Sung Il Kim
Journal:  Korean J Ophthalmol       Date:  2021-11-26

4.  Efficacy of a helicase-primase inhibitor in animal models of ocular herpes simplex virus type 1 infection.

Authors:  Herbert E Kaufman; Emily D Varnell; Bryan M Gebhardt; Hilary W Thompson; Ephraim Atwal; Helga Rübsamen-Waigmann; Gerald Kleymann
Journal:  J Ocul Pharmacol Ther       Date:  2008-02       Impact factor: 2.671

Review 5.  New concepts in herpes simplex virus vaccine development: notes from the battlefield.

Authors:  Gargi Dasgupta; Aziz A Chentoufi; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  Expert Rev Vaccines       Date:  2009-08       Impact factor: 5.217

Review 6.  Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases.

Authors:  Jody M Webre; James M Hill; Nicole M Nolan; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Victor Hsia; Donna M Neumann; Timothy P Foster; Walter J Lukiw; Hilary W Thompson
Journal:  J Biomed Biotechnol       Date:  2012-10-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.